Hypertension linked to PDE3A activation

Nature Genetics

Volumn 47, Issue 6, 2015, Pages 562-563

  Houslay, Miles ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b North Lanarkshire   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE 3A; PHOSPHODIESTERASE III; PROTEIN KINASE C; UNCLASSIFIED DRUG; PDE3A PROTEIN, HUMAN;

ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME PHOSPHORYLATION; GENE MUTATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SHORT SURVEY; ENZYMOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION;

EID: 84930067097     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3316     Document Type: Short Survey

References (15)

1. Maass, P.G. et al. Nat. Genet. 47, 647-653 (2015).
2. Lugnier, C. Pharmacol. Ther. 109, 366-398 (2006).
3. Francis, S.H. & Corbin, J.D. Expert Opin. Drug Metab. Toxicol. 1, 283-293 (2005).
4. Schafer, P.H. et al. Br. J. Pharmacol. 159, 842-855 (2010).
5. Morales Vidal, S.G. & Ruland, S. Neurol. Clin. 31, 633-657 (2013).
6. Houslay, M.D. Trends Biochem. Sci. 35, 91-100 (2010).
7. Vandeput, F. et al. Proc. Natl. Acad. Sci. USA 110, 19778-19783 (2013).
8. Burgin, A.B. et al. Nat. Biotechnol. 28, 63-70 (2010).
9. McPhee, I. et al. J. Biol. Chem. 274, 11796-11810 (1999).
10. Cedervall, P. et al. Proc. Natl. Acad. Sci. USA 112, E1414-E1422 (2015).
11. Bolger, G.B. et al. Cell. Signal. 27, 756-769 (2015).
12. Han, S.J. et al. EMBO J. 25, 5716-5725 (2006).
13. Yan, Y. et al. J. Neurol. Sci. 338, 3-11 (2014).
14. Kaname, T. et al. Cell. Signal. 26, 2446-2459 (2014).
15. Abbott-Banner, K.H. & Page, C.P. Basic Clin. Pharmacol. Toxicol. 114, 365-376 (2014).